EPREX of Janssen-Cilag gets French regulatory approval treating symptomatic anaemia in patients with low or intermediate-1- risk MDS
Posted on28 Mar 2017
Comments0
Janssen-Cilag International NV has announced the French health authority Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), has... Read More